# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-043943
Filing Date
2021-08-12
Accepted
2021-08-12 16:01:15
Documents
65
Period of Report
2021-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | rptx-10q_20210630.htm iXBRL | 10-Q | 2980956
2 | EX-10.1 | rptx-ex101_145.htm | EX-10.1 | 54326
3 | EX-10.2 | rptx-ex102_144.htm | EX-10.2 | 45017
4 | EX-10.3 | rptx-ex103_146.htm | EX-10.3 | 136090
5 | EX-10.4 | rptx-ex104_177.htm | EX-10.4 | 457264
6 | EX-31.1 | rptx-ex311_8.htm | EX-31.1 | 20056
7 | EX-31.2 | rptx-ex312_7.htm | EX-31.2 | 19945
8 | EX-32.1 | rptx-ex321_6.htm | EX-32.1 | 8557
9 | EX-32.2 | rptx-ex322_9.htm | EX-32.2 | 8561
10 | GRAPHIC | gsp5l3ss1paz000001.jpg | GRAPHIC | 193526
| Complete submission text file | 0001564590-21-043943.txt |  | 9030277

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
11 | XBRL TAXONOMY EXTENSION SCHEMA | rptx-20210630.xsd | EX-101.SCH | 41449
12 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | rptx-20210630_cal.xml | EX-101.CAL | 41775
13 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | rptx-20210630_def.xml | EX-101.DEF | 110430
14 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | rptx-20210630_lab.xml | EX-101.LAB | 331778
15 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | rptx-20210630_pre.xml | EX-101.PRE | 248670
16 | EXTRACTED XBRL INSTANCE DOCUMENT | rptx-10q_20210630_htm.xml | XML | 1346865

Mailing Address 7210 FREDERICK-BANTING, SUITE 100 ST-LAURENT A8 H4S 2A1
Business Address 7210 FREDERICK-BANTING, SUITE 100 ST-LAURENT A8 H4S 2A1 (857) 412-7018
Repare Therapeutics Inc. (Filer) CIK: 0001808158 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39335 | Film No.: 211167375
SIC: 2834 Pharmaceutical Preparations